PANACEABIO.BOPANACEABIO.BOBSE
Loading
Cash Flow Under PressureContracting
Percentile Rank29
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-776.80M
↓ 156% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-303.27M
Historical baseline
PeriodValueYoY Change
2025$-776.80M+0.2%
2024$-778.18M+83.2%
2023$-4.63B-283.1%
2022$-1.21B-242.3%
2021$850.01M+327.4%
2020$-373.81M-137.4%
2019$1.00B-2.7%
2018$1.03B-3.7%
2017$1.07B+34.5%
2016$793.70M-